Literature DB >> 11551207

Reduced activity of the NPR-A kinase triggers dephosphorylation and homologous desensitization of the receptor.

S Joubert1, J Labrecque, A De Léan.   

Abstract

NPR-A, the receptor for the atrial natriuretic peptide (ANP), is a 130-kDa protein presenting an extracellular ANP-binding domain, a single transmembrane domain, an intracellular regulatory kinase homology domain (KHD), and a guanylyl cyclase catalytic domain. Upon stimulation, NPR-A receptors are activated to produce cyclic guanosine monophosphate (cGMP) and are subsequently desensitized through dephosphorylation of residues at their KHD. We used wild-type rat (r) NPR-A (WT) and a disulfide-bridged mutant (C423S) expressed in human embryonic kidney (HEK) 293 cells to study receptor phosphorylation. We have previously characterized the C423S receptor as constitutively active and desensitized. At basal state, 32P incorporation in the rNPR-A(C423S) covalent dimer is about 24 times less efficient than incorporation in the WT rNPR-A. When membranes from WT and rNPR-A(C423S) are incubated with [35S]ATPgammaS, the mutant dimer receptor displays 3.5% of the thiophosphate incorporation found for WT rNPR-A. Since the rNPR-A(C423S) dimer is already extensively dephosphorylated, we then used the WT rNPR-A to study dephosphorylation. As previously documented, adding ANP globally induces time-dependent dephosphorylation of the receptor. However, in pulse-chase experiments with the WT rNPR-A, adding ANP during the chase does not lead to a significant effect on receptor dephosphorylation. On the other hand, thiophosphorylation of the WT rNPR-A previously desensitized with ANP is reduced to 8.3% of the incorporation for untreated receptor, similar to results found with the rNPR-A(C423S) at basal state. These results demonstrate that ANP-induced rNPR-A desensitization is modulated by a significant reduction in the activity or affinity of the rNPR-A kinase that contributes to the low phosphorylation level after induction. Moreover, we further document a close relationship between tight dimerization, dephosphorylation, and desensitization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551207     DOI: 10.1021/bi010580s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

2.  Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.

Authors:  Andrea R Yoder; Matthew D Stone; Timothy J Griffin; Lincoln R Potter
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

3.  Prolonged atrial natriuretic peptide exposure stimulates guanylyl cyclase-a degradation.

Authors:  Darcy R Flora; Lincoln R Potter
Journal:  Endocrinology       Date:  2010-04-09       Impact factor: 4.736

4.  ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

5.  A Glutamate-Substituted Mutant Mimics the Phosphorylated and Active Form of Guanylyl Cyclase-A.

Authors:  Neil M Otto; William G McDowell; Deborah M Dickey; Lincoln R Potter
Journal:  Mol Pharmacol       Date:  2017-04-17       Impact factor: 4.436

6.  Guanylyl cyclase-A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice.

Authors:  Brandon M Wagner; Jerid W Robinson; Chastity L Healy; Madeline Gauthier; Deborah M Dickey; Siu-Pok Yee; John W Osborn; Timothy D O'Connell; Lincoln R Potter
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.191

Review 7.  The pseudokinase domain in receptor guanylyl cyclases.

Authors:  Avipsa Bose; Sandhya S Visweswariah
Journal:  Methods Enzymol       Date:  2022-04-18       Impact factor: 1.682

8.  Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: Role of ROS and NF-κB.

Authors:  Venkatachalam Gopi; Vimala Subramanian; Senthamizharasi Manivasagam; Elangovan Vellaichamy
Journal:  Mol Cell Biochem       Date:  2015-07-28       Impact factor: 3.396

9.  ATP signaling site in the ARM domain of atrial natriuretic factor receptor guanylate cyclase.

Authors:  Beata Burczynska; Teresa Duda; Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2007-02-03       Impact factor: 3.842

10.  A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B.

Authors:  Andrea R Yoder; Jerid W Robinson; Deborah M Dickey; Joshua Andersland; Beth A Rose; Matthew D Stone; Timothy J Griffin; Lincoln R Potter
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.